Emmanuelle Rial‐Sebbag

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Reconciling the biomedical data commons and the GDPR: three lessons from the EUCAN ELSI collaboratory

The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice

Opportunistic genomic screening. Recommendations of the European Society of Human Genetics

European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death

Including all voices in international data-sharing governance

Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes

Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape

One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans

Legislation on direct-to-consumer genetic testing in seven European countries